Pennant Group to Participate in the 2026 RBC Global Healthcare Conference
GlobeNewswire Inc.
1 hours ago
EAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 20
Intuitive Machines Announces Two Prime Lunar Reconnaissance Contracts
GlobeNewswire Inc.
2 hours ago
HOUSTON, May 18, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”, together with its subsidiaries, the “Company”), a space technology, infrastructure, and services leader, is now the prime contractor for operatio
Exyn Announces Closing of its Initial Public Offering
GlobeNewswire Inc.
2 hours ago
PHILADELPHIA, PA, May 18, 2026 (GLOBE NEWSWIRE) -- Exyn Technologies, Inc. (“Exyn” or the “Company”) (NASDAQ: EXYN, EXYNW), a leader in autonomous mapping and perception-driven navigation for complex, GPS-denied environments, today announced the clos
Pennant Announces an Acquisition of Senior Living Community in Arizona
GlobeNewswire Inc.
2 hours ago
EAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and
Iron Dome Acquisition I Corp. Announces Closing of $150 Million Initial Public Offering
GlobeNewswire Inc.
2 hours ago
New York, New York, May 18, 2026 (GLOBE NEWSWIRE) -- Iron Dome Acquisition I Corp. (the “Company”), a special purpose acquisition company, today announced the closing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. T
Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress
GlobeNewswire Inc.
2 hours ago
CAMBRIDGE, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and cancer, today a
Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise Customer
GlobeNewswire Inc.
2 hours ago
Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute CareDETROIT, May 18, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI-native NurseMagic™ documentati
Sigma Lithium Filing Legal Appeal Against Unwarranted Decision by a Local Judge; "Fake News" Campaign Coincides with Record Earnings
Newsfile
2 hours ago
São Paulo, Brazil--(Newsfile Corp. - May 18, 2026) - Sigma Lithium Corporation (NASDAQ: SGML) (TSXV: SGML) (BVMF: S2GM34) ("Sigma Lithium" or the "Company"), the largest producer of lithium oxide concentrate in the Americas¹ and dedicated to industri
Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
GlobeNewswire Inc.
3 hours ago
LITTLETON, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, will participa
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
GlobeNewswire Inc.
3 hours ago
Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with monthly dosing On track for feedback from FDA on pot

